EFFECTS OF PROPRANOLOL ON RESPONSE TO EXERCISE IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

EFFECTS OF PROPRANOLOL ON RESPONSE TO EXERCISE IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY

Show other versions (1)

Bibliographic Details
Main Authors:	Edwards, R, Kristins, A, Warrell, D, Goodwin, J
Format:	Journal article
Published:	1970

Similar Items

Effects of propranolol on response to exercise in hypertrophic obstructive cardiomyopathy.
by: Edwards, R, et al.
Published: (1970)

INTEGRATED RESPONSE TO EXERCISE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AND EFFECT OF BETA-ADRENERGIC BLOCKADE ON OXYGEN TRANSPORT
by: Edwards, R, et al.
Published: (1969)

Integrated response to exercise in patients with hypertrophic obstructive cardiomyopathy and effect of beta-adrenergic blockade on oxygen transport.
by: Edwards, R, et al.
Published: (1969)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
by: Watkins, H, et al.
Published: (2005)

Cardiac energetic impairment in non-obstructive hypertrophic cardiomyopathy: relation to exercise capacity and dynamic diastolic dysfunction
by: Abozguia, K, et al.
Published: (2009)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
by: Coppini, R, et al.
Published: (2019)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
by: Wordsworth, S, et al.
Published: (2006)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2024)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

Myocardial dysfunction in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2001)

The genetic architecture of hypertrophic cardiomyopathy
by: Harper, AR
Published: (2020)

Exercise-induced ventricular dysfunction in hypertrophic cardiomyopathy: stunning by any other name?
by: Ashrafian, H, et al.
Published: (2008)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
by: Kramer, CM, et al.
Published: (2018)

Linked genetic modifiers in hypertrophic cardiomyopathy
by: Ektisham, J, et al.
Published: (2004)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
by: Suttie, J, et al.
Published: (2011)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
by: Ashrafian, H, et al.
Published: (2005)

The genetics of hypertrophic cardiomyopathy: Teare redux.
by: Watkins, H, et al.
Published: (2008)

EFFECT OF PROPRANOLOL ON ARTERIAL PLASMA POTASSIUM ([K+]A) AND VENTILATION DURING EXERCISE IN MAN
by: Paterson, D, et al.
Published: (1991)

Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy.
by: Abozguia, K, et al.
Published: (2010)

Metabolic Modulation With Perhexiline Corrects Energy Deficiency and Improves Exercise Capacity in Symptomatic Hypertrophic Cardiomyopathy
by: Abozguia, K, et al.
Published: (2009)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
by: Wordsworth, S, et al.
Published: (2010)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
by: Wordsworth, S, et al.
Published: (2010)

Mouse Model of Familial Hypertrophic Cardiomyopathy with E99K ACTC Mutation Recapitulates Many Features of Hypertrophic Cardiomyopathy in Patients
by: Song, W, et al.
Published: (2008)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
by: Pal, N
Published: (2015)

ST segment "hump" during exercise testing and the risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
by: Michaelides, A, et al.
Published: (2009)

Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T.
by: Bayliss, C, et al.
Published: (2013)

Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin
by: Toepfer, C, et al.
Published: (2019)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
by: Palandri, C, et al.
Published: (2022)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
by: Karamitsos, T, et al.
Published: (2013)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
by: Chow, J, et al.
Published: (2024)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
by: Neubauer, S, et al.
Published: (2019)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2023)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2011)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
by: Blair, E, et al.
Published: (2003)

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: do mitral valve leaflet length, septal thickness, or sex affect the outcome?
by: Mustafic, Mesud, et al.
Published: (2024)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: Abozguia, K, et al.
Published: (2010)